Asian Journal of Dairy and Food Research

Asian Journal of Dairy and Food Research cover
Volume 44 · 2025/07/02

Estimation of Coagulation FXlll and FXIII A1 Serum Levels in Iraqi Individuals Affected with FXIII Deficiency

Murtadha A. Alshami
Asmaa Mohammed
229 Views

Submitted

2025/03/31

First Online

2025/07/02

doi

10.18805/ajdfr.DRF-532

Cite article - Murtadha A. Alshami, Asmaa Mohammed. (2025). Estimation of Coagulation FXlll and FXIII A1 Serum Levels in Iraqi Individuals Affected with FXIII Deficiency. Asian Journal of Dairy and Food Research. 44: 122–128. doi: 10.18805/ajdfr.DRF-532

Abstract

Background: The uncommon bleeding condition known as factor XIII (FXIII) deficiency can cause symptoms that range from cerebral hemorrhage to delayed umbilical cord separation. When activated, FXIII is essential for maintaining clot stability and promoting fibrin polymer cross-linking, which guarantees efficient hemostasis. A genetic or acquired FXIII deficiency can cause aberrant bleeding tendencies and decreased clot stability. In Iraq, FXIIID is a common rare bleeding disorder.

Methods : Samples included in this study were families that have some affected individuals with coagulation factor XIII deficiency and healthy persons that are unaffected by any bleeding disorder, with different ages and from different areas of Baghdad- Iraq, to determine FXIII and FXIII-A1 serum levels by Elisa among different genotype individual affected with FXIII deficiency with hime families in addition to recounting some of the coagulation tests (PT, PTT, INR and platelete account).

Result: The results revealed a statistically significant difference in platelet counts between the two groups (P<0.01), with affected individuals exhibiting a significantly higher mean platelet count (240.20 *10 9 /L±70.21) compared to the control group (201.05*10 9 /L ±27.64). Affected individuals exhibited a significantly shorter PTT (31.60 s±4.36) compared to the control group (33.88 s±2.74) with a P-value (P=0.04), while their INR values were significantly higher (1.12±0.20) compared to controls (0.99±0.12) (P=0.02). No significant difference was observed in PT values between the two groups. the mean of FXIII-A1 was (2.38, 2.86 and 7.54) ng/ml and the mean of FXIII in total was (212.51, 222.81 and 230.38) ng/ml, respectively; homozygote, heterozygote and control group. In a comparison of the difference in the level of FXIII and FXIII A1 between the affected and the control, the rate decrease in the level of FXIII as a whole is approximately 36% below the normal level, while the rate decrease in FXIII A1 is approximately 69% below the normal level.

References

  1. Abass, S.F., Hussein, M.S., Hasan, A.F., Al-Dulimi, A.G. and El-Wahsh, H.M. (2025). Effect of bee venom ( Apis mellifera ) on liver damage in mice with Ehrlich ascites carcinoma. Regulatory Mechanisms in Biosystems . 16(1): e25040-e25040. Abd El-Rahmana, H.A., Hasanb, A.F., Alyasiric, T., El-Wahshd, H.M., Althubyanie, S.A., Basyonyf, M.A. and Mahmodf, D.H. (2024). Co-treatment with cranberry and vitamin-C mitigates reproductive toxicities induced by phenobarbital in male rats. Cell Physiol Biochem . 58: 722-738. Al-Dulimi, A.G., Naema, A.F., Zedan, Z.K., Mohammed, I.H., Jabar, A.M. and Abdulateef, M.H. (2023, March). RGD-coupled gold nanoparticles initiate apoptosis in human cancer cells. In AIP Conference Proceedings. AIP Publishing . 2475: 1. Al-Khuzaay, H.M., Al-Juraisy, Y.H., Hasan, A.F. and Tousson, E. (2024). Antitumor activity of β-glucan isolated &agrave;rom date fruits щn cancer cells in vivo . Opera Medica et Physiologica . 11(3): 41-48. Al-Maliki, N.S. and Zedan, Z.K. (2024). miRNA-126 as a biomarker for cancer stem cells: Role in chemotherapy resistance in Iraqi patients with acute myeloid leukemia. Al-Rafidain Journal of Medical Sciences. 6(1): 195-199. (ISSN 2789-3219). Al-Maliki, N.S., Jumaah, Y.H., Hameed, H.M., Khudhair, O.E., Hadid, M.A. and Hasan, A.F. (2025). Evaluation of miRNA-155 as a biomarker for cancer stem cells and its role in chemotherapy resistance in Iraqi patients with acute myeloid Leukemia. Opera Medica et Physiologica . 12(1): 30-37. Alshehri, F.S., Whyte, C.S. and Mutch, N.J. (2021). Factor XIII-A: An indispensable “factor” in haemostasis and wound healing. International Journal of Molecular Sciences . 22(6): 3055. Altemeemi, A.S., Kadhim, N.K. and Nsaif, G.S. (2021). Changes in interleukins and follicle stimulating hormone in toxo- plasmosis male patients. Indian Journal of Forensic Medicine and Toxicology . 15(1): 803-807. Alyasiri, T., Hameed, H.M. and Hasan, A.F. (2024). The effects of bisphenol A of polycarbonate plastics on various blood and fertility parameters, along with histological changes in male albino rats. Asian Journal of Dairy and Food Research . 44(2): 313-319. doi: 10.18805/ajdfr.DRF- 435 . Badulescu, O.V., Badescu, M.C., Bojan, I.B., Vladeanu, M., Filip, N., Dobreanu, S., Tudor, R., Ciuntu, B.-M., Tanevski, A. and Ciocoiu, M. (2024). Thrombotic disease in hemophilic patients: Is this a paradox in a state of hypocoagulability? Diagnostics . 14(3): 286. Batsuli, G. and Kouides, P. (2021). Rare coagulation factor deficiencies (factors VII, X, V and II). Hematology/Oncology Clinics . 35(6): 1181-1196. Butenas, S., Mann, K.G. and Butenas. (2002). Blood coagulation. Biochemistry (Moscow) . 67: 3-12. Byrnes, J.R., Lee, T., Sharaby, S., Campbell, R.A., Dobson, D.V.A., Holle, L.A., Luo, M., Kangro, K., Homeister, J.W., Aleman, M.M. and Luyendyk, J.P. (2024). Reciprocal stabilization of coagulation factor XIII-A and-B subunits is a determinant of plasma FXIII concentration. Blood . 143(5): 444. Byrnes, J.R., Lee, T., Sharaby, S., Campbell, R.A., Dobson, D.V.A., Holle, L.A., Luo, M., Kangro, K., Homeister, J.W., Aleman, M.M. and Luyendyk, J.P. (2024). Reciprocal stabilization of coagulation factor XIII-A and-B subunits is a determinant of plasma FXIII concentration. Blood . 143(5): 444- 455. Dull, K., Fazekas, F. and T&ouml;r&otilde;csik, D. (2021). Factor XIII-A in diseases: Role beyond blood coagulation. International Journal of Molecular Sciences. 22(3): 1459. Elsamie, G.H.A., El-Banna, S.G., Tousson, E., Felemban, S.G. and Hussein, M.S. (2021). Impact of vitamin B17 against growth of colitis bearing mice induced variations in colon structure, AFP, CEA and PCNA immunoreactivity. Online Journal of Biological Sciences . 21(3): 228-234. https:// doi.org/10.3844/ojbsci.2021.228.234. Favaloro, E.J., Kershaw, G., Mohammed, S. and Lippi, G. (2019). How to optimize activated partial thromboplastin time (APTT) testing: Solutions to establishing and verifying normal reference intervals and assessing APTT reagents for sensitivity to heparin, lupus anticoagulant and clotting factors. In Seminars in thrombosis and hemostasis, Thieme Medical Publishers . 45(01): 022-035. Ghiath, Y., Mtashar, B.A., AL-Zuhairy, N.A.H.S., Hussein, M.S. and Hasan, A.F. (2025). Interplaying correlation of some genetic and inflammatory factors among patients with polycythemia vera. Asian Journal of Dairy and Food Research . 1-6. doi: 10.18805/ajdfr.DRF-492. Gyurina, K., K&aacute;rai, B., Ujfalusi, A., Hevessy, Z., Barna, G., J&aacute;ks&oacute;, P. and Kiss, C. (2019). Coagulation FXIII-A protein expression defines three novel sub-populations in pediatric B-cell progenitor acute lymphoblastic leukemia characterized by distinct gene expression signatures. Frontiers in Oncology . 9: 1063. Hameed, H.M., Razooki, Z.H. and Hasan, A.F. (2024). Therapeutic effect of essential oils ( Citrus sinensis ) against ehrlich ascites model induced renal toxicity in female mice. Agricultural Science Digest . 45(2): 317-322. doi: 10. 18805/ag.DF-632 . Hmeed, E.Z., Mtashar, B.A., Ghiath, Y., Al-Alwany, S.H.M., Hussein, M.S. and Faraj, Y.F. (2025). Investigation of TYMS (rs 2853542) polymorphism and cytomegalovirus in patients with acute lymphoblastic leukemia. Journal of Bioscience and Applied Research . 11(1): 233-242. Hoffman, R., Benz, E.J., Silberstein, L.E., Heslop, H., Weitz, J. and Salama, M.E. (Eds.). (2022). Hematology E-book: Basic principles and practice. Elsevier Health Sciences. Hurj&aacute;k, B., Kov&aacute;cs, Z., D&ouml;ncz&otilde;, B., Katona, &Eacute;., Haramura, G., Erd&eacute;lyi, F., Shemirani, A.H., Sadeghi, F., Muszbek, L. and Guttman, A. (2020). N glycosylation of blood coagulation factor XIII subunit B and its functional consequence. Journal of Thrombosis and Haemostasis . 18(6): 1302-1309. Ichinose, A. (2001). Physiopathology and regulation of factor XIII. Thrombosis and haemostasis . 86(07): 57-65. Kareem, K.N. and Zwamel, A.H. (2023). The GGC medium reduces the DNA fragmentation of human spermatozoa via in vitro activation. Archives of Razi Institute . 78(2): 709-714. Karimi, M., Peyvandi, F., Naderi, M. and Shapiro, A. (2018). Factor XIII deficiency diagnosis: Challenges and tools. International Journal of Laboratory Hematology . 40(1): 3-11. Karpati, L., Penke, B., Katona, E., Balogh, I., Vamosi, G. and Muszbek, L. (2000). A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clinical Chemistry . 46(12): 1946-1955. Katona, &Eacute;., Haramura, G., K&aacute;rp&aacute;ti, L., Fachet, J. and Muszbek, L. (2000). A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A 2 B 2 ). Thrombosis and Haemostasis . 83(02): 268-273. M Obaid, R., Tareq Yaseen, F., Kareem Kadhim, N., Hameed Salim, D., Tarq Sabar, Z., Sahib Abd, D. and Hasan, A.F. (2025). Changes in the level of lipid profile in diabetes mellitus in samples patients. Journal of Bioscience and Applied Research . 11(1): 331-336. Mangla, A., Hamad, H., Killeen, R. B., and Kumar, A. (2024). Factor XIII deficiency. In StatPearls [Internet]. StatPearls Publishing. Muszbek, L., Katona, &Eacute;. and Ker&eacute;nyi, A. (2017). Assessment of factor XIII. Hemostasis and Thrombosis: Methods and Protocols. 277-293. Nahm, F.S. (2022) Receiver operating characteristic curve: Overview and practical use for clinicians. Korean Journal of Anesthesiology . 75: 25-36. Nurden, P., Stritt, S., Favier, R. and Nurden, A. T. (2021). Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy. Haematologica . 106(2): 337. Patalakh, I., Revka, O., Go³aszewska, A., Bielicka, N. and Misztal, T. (2024). Integration of clotting and fibrinolysis: Central role of platelets and factor XIIIa. Bioscience Reports . BSR20240332. Pelcovits, A., Schiffman, F. and Niroula, R. (2021) Factor XIII deficiency: A review of clinical presentation and management. Hematol Oncol Clin North Am . (6): 1171-1180. Sachs, M.C. (2017). PlotROC: A Tool for Plotting ROC Curves. Journal of Statistical Software. 79(Code Snippet 2). Saleh, M.M., Sabbah, M.A. and Zedan, Z.K. (2024). Isolation and characterization of three lytic bacteriophages to overcome multidrug-, extensive drug-and pandrug-resistant pseudomonas aeruginosa. PHAGE . 5(4): 230-240. Strilchuk, A.W., Meixner, S.C., Leung, J., Safikhan, N.S., Kulkarni, J.A., Russell, H.M., van der Meel, R., Sutherland, M.R., Owens III, A.P., Palumbo, J.S. and Conway, E.M. (2020). Sustained depletion of FXIII-A by inducing acquired FXIII- B deficiency. Blood, The Journal of the American Society of Hematology . 136(25): 2946-2954. Thomas, A. (2018). Characterization of the structural-functional impact of heterozygous missense mutations in genes of the blood coagulation factor XIII that cause mild Factor XIII deficiency. PhD Thesis. Dissertation, Bonn, Rheinische Friedrich-Wilhelms-Universit&auml;t Bonn. T&ouml;r&ouml;csik, D., Sz&eacute;les, L., Paragh Jr, G., R&aacute;kosy, Z., B&aacute;rdos, H., Nagy, L. and &Aacute;d&aacute;ny, R. (2010). Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophages. Thrombosis and Haemostasis . 104(10): 709-717. Wolberg, A.S. and Sang, Y. (2022). Fibrinogen and factor XIII in venous thrombosis and thrombus stability. Arteriosclerosis, Thrombosis and Vascular Biology . 42(8): 931-941. Yahya, A., Adil Obaid, W., Mohammed Hameed, O. and Hasan, A.F. (2024). Histopathological and immunohistochemical studies on the effects of silver oxide nanoparticles (AgNPs) on male rats’ liver. Journal of Bioscience and Applied Research . 10(3): 392-398. Yan, M.T.S., Rydz, N., Goodyear, D. and Sholzberg, M. (2018). Acquired factor XIII deficiency: A review. Transfusion and Apheresis Science . 57(6): 724-730. Zedan, Z.K. and AL-Amer, S.H. (2022). The dysregulation of mir- 21 and mir-143 as a clinical marker for cancer stem cells in tissue samples of Iraqi male patients with gastro- intestinal sarcoma. Journal of Pharmaceutical Negative Results Volume . 13(3): 20. Zhang, P., Zhang, R. and Jing, C. (2024). Abnormal bleeding after lumbar vertebrae surgery because of acquired factor XIII deficiency: A case report and literature review. Medicine . 103(2): e36944.
EDITORIAL BOARD

Guided by Experienced Academic Leadership

Distinguished scholars and subject experts committed to editorial excellence, scientific integrity and rigorous peer review.

View Full Board
Harjinder Singh
Chief Editor

Harjinder Singh

DirectorMassey Institute of Food Science and Technology, NEW ZEALAND

Tanweer Alam
Associate chief editor

Tanweer Alam

DirectorIndian Institute of Packaging, Mumbai, Maharashtra, INDIA

Mridula Devi
Editor

Mridula Devi

DirectorICAR-Central Institute for Women in Agriculture, Bhubaneswar, Odisha, India

A. Elango
Editor

A. Elango

DeanVeterinary College and Research Institute, Salem, Tamil Nadu Veterinary and Animal Sciences University, T.N., INDIA